Copyright
©The Author(s) 2023.
World J Clin Cases. Apr 6, 2023; 11(10): 2168-2180
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2168
Published online Apr 6, 2023. doi: 10.12998/wjcc.v11.i10.2168
Table 1 Seropositive rates of severe acute respiratory distress syndrome coronavirus-2-specific immunoglobulin G and immunoglobulin M at various time points after symptom onset
| Days after symptom onset | IgM positivity rate (%) | IgG positivity rate (%) |
| 0–5 | 44/118 (37.3) | 71/118 (60.2) |
| 6–15 | 36/55 (65.5) | 44/55 (80.0) |
| 16–25 | 48/70 (68.6) | 56/70 (80.0) |
| 26–35 | 26/56 (46.4) | 2/56 (75.0) |
| 36–95 | 17/95 (17.9) | 56/95 (58.9) |
- Citation: Sun J, Yang ZD, Xie X, Li L, Zeng HS, Gong B, Xu JQ, Wu JH, Qu BB, Song GW. Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19. World J Clin Cases 2023; 11(10): 2168-2180
- URL: https://www.wjgnet.com/2307-8960/full/v11/i10/2168.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i10.2168